Singh Ashutosh K, Kaur Manpreet, Patel Nishant, Aggarwal Richa, Trikha Anjan
Department of Anesthesiology, Pain Medicine and Critical Care, All India Institute of Medical Sciences, New Delhi, IND.
Department of Critical and Intensive Care, Jai Prakash Narayan (JPN) Apex Trauma Centre, All India Institute of Medical Sciences, New Delhi, IND.
Cureus. 2022 Feb 26;14(2):e22641. doi: 10.7759/cureus.22641. eCollection 2022 Feb.
High-flow nasal cannula (HFNC) is one of the most commonly used devices for oxygen therapy during the coronavirus disease 2019 (COVID-19) pandemic in different hospital settings. Multiple alternative options include non-invasive and invasive ventilation. But non-invasive ventilation is very uncomfortable for patients, and weaning from invasive ventilation in a patient with lung pathology is challenging. Hence, HFNC has come up as a safe alternative that averts invasive ventilation. However, its widespread application is difficult in patients with nasal deformities. We discuss two patients, one with caudal dislocation of the nasal septum with a crooked nose and the other patient with septal hypertrophy. In both cases, invasive ventilation was deferred, and target oxygen saturation was achieved after a simple dispositive modification.
高流量鼻导管（HFNC）是2019冠状病毒病（COVID-19）大流行期间不同医院环境中最常用的氧疗设备之一。多种替代方案包括无创通气和有创通气。但无创通气让患者非常不舒服，而对于肺部病变患者，撤离有创通气具有挑战性。因此，HFNC已成为一种避免有创通气的安全替代方案。然而，它在鼻畸形患者中难以广泛应用。我们讨论两名患者，一名鼻中隔尾端脱位伴歪鼻，另一名患者鼻中隔肥大。在这两种情况下，均推迟了有创通气，经过简单的处置修改后达到了目标氧饱和度。
